Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Catheter ablation of accessory pathway: 14-year trends in utilization and complications in adults in the United States.

Garg J, Shah N, Krishnamoorthy P, Mehta K, Bozorgnia B, Boyle NG, Freudenberger R, Natale A.

Int J Cardiol. 2017 Jun 30. pii: S0167-5273(17)31622-4. doi: 10.1016/j.ijcard.2017.06.115. [Epub ahead of print]

PMID:
28712558
2.

Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.

Nakanishi K, Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

Cerebrovasc Dis. 2017 Apr 19;44(1-2):43-50. doi: 10.1159/000474958. [Epub ahead of print]

PMID:
28419982
3.

On-X Valve: The Next Generation Aortic Valve.

Chaudhary R, Garg J, Krishnamoorthy P, Shah N, Feldman BA, Martinez MW, Freudenberger R.

Cardiol Rev. 2017 Mar/Apr;25(2):77-83. doi: 10.1097/CRD.0000000000000105. Review.

PMID:
28170357
4.

Reply: Do We Need Individualized Therapeutic Strategies in High-Risk Patients Treated With Hypothermia?

Shah N, Chaudhary R, Mehta K, Agarwal V, Garg J, Freudenberger R, Jacobs L, Cox D, Kern KB, Patel N.

JACC Cardiovasc Interv. 2017 Jan 9;10(1):105-106. doi: 10.1016/j.jcin.2016.11.015. No abstract available.

PMID:
28057280
5.

Therapeutic Hypothermia and Stent Thrombosis: A Nationwide Analysis.

Shah N, Chaudhary R, Mehta K, Agarwal V, Garg J, Freudenberger R, Jacobs L, Cox D, Kern KB, Patel N.

JACC Cardiovasc Interv. 2016 Sep 12;9(17):1801-11. doi: 10.1016/j.jcin.2016.06.052.

PMID:
27609254
6.

CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.

Ye S, Qian M, Zhao B, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Lip GY, Thompson JL, Homma S; WARCEF Investigators.

Eur J Heart Fail. 2016 Oct;18(10):1261-1266. doi: 10.1002/ejhf.613. Epub 2016 Jul 21.

PMID:
27444219
7.

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.

Di Tullio MR, Qian M, Thompson JL, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GY, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

Stroke. 2016 Aug;47(8):2031-7. doi: 10.1161/STROKEAHA.116.013679. Epub 2016 Jun 28.

PMID:
27354224
8.

Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus.

Shah M, Garg J, Patel B, Guthier J, Freudenberger RS.

Int J Cardiol. 2016 Jul 15;215:129-31. doi: 10.1016/j.ijcard.2016.04.055. Epub 2016 Apr 14. No abstract available.

PMID:
27111175
9.

The Current Approach to Diagnosis and Management of Left Ventricular Noncompaction Cardiomyopathy: Review of the Literature.

Bennett CE, Freudenberger R.

Cardiol Res Pract. 2016;2016:5172308. doi: 10.1155/2016/5172308. Epub 2016 Jan 11. Review.

10.

Cardiotoxicity of Anticancer Therapies.

Muppidi R, Spranklin L, Scialla W, Islam N, Freudenberger R, Malacoff R.

Rev Cardiovasc Med. 2015;16(4):225-34.

PMID:
26827744
11.

Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial.

Kato TS, Di Tullio MR, Qian M, Wu M, Thompson JL, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GY, Levin B, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

Circ J. 2016;80(3):619-26. doi: 10.1253/circj.CJ-15-1054. Epub 2016 Jan 22.

12.

Ivabradine: Heart Failure and Beyond.

Chaudhary R, Garg J, Krishnamoorthy P, Shah N, Lanier G, Martinez MW, Freudenberger R.

J Cardiovasc Pharmacol Ther. 2016 Jul;21(4):335-43. doi: 10.1177/1074248415624157. Epub 2015 Dec 31.

PMID:
26721645
13.

National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.

Shah N, Agarwal V, Patel N, Deshmukh A, Chothani A, Garg J, Badheka A, Martinez M, Islam N, Freudenberger R.

Ann Thorac Surg. 2016 Apr;101(4):1477-84. doi: 10.1016/j.athoracsur.2015.09.013. Epub 2015 Nov 14.

PMID:
26588867
14.

The first prognostic model for stroke and death in patients with systolic heart failure.

Freudenberger RS, Cheng B, Mann DL, Thompson JL, Sacco RL, Buchsbaum R, Sanford A, Pullicino PM, Levin B, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Di Tullio MR, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

J Cardiol. 2016 Aug;68(2):100-3. doi: 10.1016/j.jjcc.2015.09.014. Epub 2015 Nov 6.

PMID:
26549533
15.

Impact of Annual Hospital Volume on Outcomes after Left Ventricular Assist Device (LVAD) Implantation in the Contemporary Era.

Shah N, Chothani A, Agarwal V, Deshmukh A, Patel N, Garg J, Badheka A, Martinez M, Islam N, Freudenberger R.

J Card Fail. 2016 Mar;22(3):232-7. doi: 10.1016/j.cardfail.2015.10.016. Epub 2015 Nov 4.

PMID:
26547012
16.

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.

Ye S, Cheng B, Lip GY, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Qian M, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators.

Am J Cardiol. 2015 Sep 15;116(6):904-12. doi: 10.1016/j.amjcard.2015.06.016. Epub 2015 Jun 24.

17.

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators.

Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7.

18.

Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial.

Shaffer JA, Thompson JL, Cheng B, Ye S, Lip GY, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Graham S, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Di Tullio MR, Homma S; WARCEF Investigators.

Int J Cardiol. 2014 Dec 15;177(2):715-7. No abstract available.

19.

Pregnancy in women after coronary revascularization.

Quiñones JN, Cox D, Smolinski WJ, Maksimik CA, Coassolo KM, Freudenberger R.

Obstet Med. 2014 Dec;7(4):168-70. doi: 10.1177/1753495X14546434. Epub 2014 Aug 15.

20.

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Graham S, Ye S, Qian M, Sanford AR, Di Tullio MR, Sacco RL, Mann DL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Labovitz AJ, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators.

PLoS One. 2014 Nov 26;9(11):e113447. doi: 10.1371/journal.pone.0113447. eCollection 2014.

Supplemental Content

Loading ...
Support Center